Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,273–3,280 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Pfizer Inc. Etrasimod - (CULTIVATE) Crohn's disease Phase 2/3 Oral Gastroenterology
Pfizer Inc. Danuglipron (PF-06882961) Obesity and without type 2 diabetes Phase 2b Trial Discontinued Oral Endocrinology
Pfizer Inc. Danuglipron (PF-06882961) Type 2 diabetes mellitus (T2DM) Phase 2b Trial Discontinued Oral Endocrinology
Pfizer Inc. Vupanorsen (AKCEA-ANGPTL3-LRx) - (TRANSLATE-TIMI 70) Cardiovascular (CV) risk reduction and hypertriglyceridemia Phase 2b Subcutaneous Cardiology
Pfizer Inc. Brepocitinib Systemic lupus erythematosus (SLE) Phase 2b Trial Discontinued Oral Immunology
Pfizer Inc. RSVpreF (PF-06482077) RSV-associated lower respiratory tract illness Phase 2b Intramuscular Respiratory
Pfizer Inc. RIST4721 Palmoplantar Pustulosis Phase 2b Oral #N/A
Pfizer Inc. Etrasimod Eosinophilic esophagitis (EoE) Phase 2b Oral Gastroenterology